Cargando…
Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060715/ https://www.ncbi.nlm.nih.gov/pubmed/35513183 http://dx.doi.org/10.1016/j.jhin.2022.04.011 |
| _version_ | 1784698564376526848 |
|---|---|
| author | Ribeiro Baptista, J.P. Wozniaki, N. Cassi, H.V. Neves, G.D. Boettcher, I.S. Dall'Oglio, A.C. Tavares, F.S. Gastal, G.R. Schwingel, F.L. de Lacerda, M.P. |
| author_facet | Ribeiro Baptista, J.P. Wozniaki, N. Cassi, H.V. Neves, G.D. Boettcher, I.S. Dall'Oglio, A.C. Tavares, F.S. Gastal, G.R. Schwingel, F.L. de Lacerda, M.P. |
| author_sort | Ribeiro Baptista, J.P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9060715 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd on behalf of The Healthcare Infection Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90607152022-05-03 Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies Ribeiro Baptista, J.P. Wozniaki, N. Cassi, H.V. Neves, G.D. Boettcher, I.S. Dall'Oglio, A.C. Tavares, F.S. Gastal, G.R. Schwingel, F.L. de Lacerda, M.P. J Hosp Infect Letter to the Editor Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2022-08 2022-05-02 /pmc/articles/PMC9060715/ /pubmed/35513183 http://dx.doi.org/10.1016/j.jhin.2022.04.011 Text en © 2022 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ribeiro Baptista, J.P. Wozniaki, N. Cassi, H.V. Neves, G.D. Boettcher, I.S. Dall'Oglio, A.C. Tavares, F.S. Gastal, G.R. Schwingel, F.L. de Lacerda, M.P. Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title | Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title_full | Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title_fullStr | Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title_full_unstemmed | Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title_short | Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies |
| title_sort | severity and 1-year cumulative incidence of covid-19 among inpatients with haematologic malignancies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060715/ https://www.ncbi.nlm.nih.gov/pubmed/35513183 http://dx.doi.org/10.1016/j.jhin.2022.04.011 |
| work_keys_str_mv | AT ribeirobaptistajp severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT wozniakin severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT cassihv severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT nevesgd severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT boettcheris severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT dalloglioac severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT tavaresfs severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT gastalgr severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT schwingelfl severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies AT delacerdamp severityand1yearcumulativeincidenceofcovid19amonginpatientswithhaematologicmalignancies |